- Home
- HPAI vs TKNO Comparison
HPAI vs TKNO Comparison
Compare HPAI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPAI
- TKNO
- Stock Information
- Founded
- HPAI 2023
- TKNO 1996
- Country
- HPAI Singapore
- TKNO United States
- Employees
- HPAI N/A
- TKNO N/A
- Industry
- HPAI
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- HPAI
- TKNO Health Care
- Exchange
- HPAI NYSE
- TKNO Nasdaq
- Market Cap
- HPAI 234.3M
- TKNO 244.7M
- IPO Year
- HPAI N/A
- TKNO 2021
- Fundamental
- Price
- HPAI $4.76
- TKNO $5.91
- Analyst Decision
- HPAI
- TKNO Buy
- Analyst Count
- HPAI 0
- TKNO 2
- Target Price
- HPAI N/A
- TKNO $5.00
- AVG Volume (30 Days)
- HPAI 36.2K
- TKNO 269.2K
- Earning Date
- HPAI 11-26-2024
- TKNO 11-07-2024
- Dividend Yield
- HPAI N/A
- TKNO N/A
- EPS Growth
- HPAI N/A
- TKNO N/A
- EPS
- HPAI N/A
- TKNO N/A
- Revenue
- HPAI $29,575,625.00
- TKNO $36,347,000.00
- Revenue This Year
- HPAI N/A
- TKNO $3.56
- Revenue Next Year
- HPAI N/A
- TKNO $13.31
- P/E Ratio
- HPAI $23.99
- TKNO N/A
- Revenue Growth
- HPAI 132.36
- TKNO N/A
- 52 Week Low
- HPAI $3.07
- TKNO $1.16
- 52 Week High
- HPAI $14.74
- TKNO $7.92
- Technical
- Relative Strength Index (RSI)
- HPAI N/A
- TKNO 44.25
- Support Level
- HPAI N/A
- TKNO $6.15
- Resistance Level
- HPAI N/A
- TKNO $7.92
- Average True Range (ATR)
- HPAI 0.00
- TKNO 0.69
- MACD
- HPAI 0.00
- TKNO -0.17
- Stochastic Oscillator
- HPAI 0.00
- TKNO 0.50
About HPAI HELPORT AI LTD
Helport AI Ltd is a AI technology company based in Singapore dedicated to serving enterprises' customer contact centers with intelligent products, solutions, and a digital platform. Its software, Helport AI Assist (AI Assist), provides tailored AI-powered guidance and oversight for contact center interactions and customer experience, with functions including Agent Assistant, Quality Assurance (QA) Assistant, Supervisor Assistant, and Knowledge Base Assistant.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.